Speaker illustration

Doctor Bassam Atallah

Cleveland Clinic, Abu Dhabi (United Arab Emirates)

Bassam Atallah, Pharm.D., M.S., BCPS-AQ Cardiology, FHFSA Dr Atallah is the Heart and Vascular Institute pharmacotherapy specialist at Cleveland Clinic Abu Dhabi. Prior to joining CCAD he was on faculty as Assistant Professor of Clinical Pharmacy at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in Riyadh, Kingdom of Saudi Arabia. Dr. Atallah received his PharmD from Bernard J. Dunn School of Pharmacy in Virginia and completed an ASHP accredited post graduate residency at Winchester Medical Center in Virginia. Dr. Atallah is board certified in pharmacotherapy with added qualifications in Cardiology. He also holds an advanced antithrombotic management certificate from the American Society of Health-System Pharmacists. He is a fellow of Heart Failure Society of America (HFSA) and Middle East Ambassador. He has several publications and presentations at national and international conferences.

Factors influencing apixaban dosing in the middle east gulf region

Event: ESC Asia with APSC & AFC

Topic: Antiarrhythmic Pharmacotherapy

Session: Poster Session Sunday


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb